Literature DB >> 31501758

A novel screening system based on gene targeting to enrich the modified mammalian cells: without leaving selection marker and additional sequence.

Abtin Behmardi1, Majid Shahbazi1, Masoud Golalipour1, Touraj Farazmandfar1.   

Abstract

Gene targeting by homologous recombination (HR) has some disadvantages in screening modified cells that limits their use in targeting gene fragments in long exons. These disadvantages include retention of remaining selection marker after targeting, not removing cells with vector random integration, and leaving loxP sequences after removal of selection markers. Therefore, to overcome these disadvantages, we decided to design a eukaryotic two-step screening system to isolate the favorable, edited cells from undesirable cells in a gene targeting project. This system included two targeting plasmids containing one positive marker and two inducible negative markers. It was designed in such a way that, during the two-step HR and subsequent selection, only the well-edited cells survive and cells with vector random integration, and untargeted and episomal targeting plasmids are eliminated. The percentage of GFP-positive cells in two-step screening method (76.10 ± 3.50) was significantly higher than in the one-step screening method (0.90 ± 0.37) (p < 0.0001). GFP noise caused by the presence of the GFP-episomal expression plasmid had no significant effect on our results. We developed an efficient system to screen and enrich the HR-modified cells from undesired-HR and untargeted cells, without leaving the selection markers in mammalian cells. This method may be a promising method in ex vivo gene therapy approaches, especially when the target is a gene fragment within a large exon.

Entities:  

Keywords:  Gene targeting; Homologous recombination; Screening; Selection marker

Year:  2019        PMID: 31501758      PMCID: PMC6728399          DOI: 10.1007/s13205-019-1884-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  21 in total

1.  Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker.

Authors:  Y Yanagawa; T Kobayashi; M Ohnishi; T Kobayashi; S Tamura; T Tsuzuki; M Sanbo; T Yagi; F Tashiro; J Miyazaki
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

2.  Efficient repetitive alteration of the mouse Huntington's disease gene by management of background in the tag and exchange gene targeting strategy.

Authors:  J A Cearley; P J Detloff
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

Review 3.  Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis.

Authors:  U Müller
Journal:  Mech Dev       Date:  1999-04       Impact factor: 1.882

4.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

5.  Problem-solving test: conditional gene targeting using the Cre/loxP recombination system.

Authors:  József Szeberényi
Journal:  Biochem Mol Biol Educ       Date:  2013 Nov-Dec       Impact factor: 1.160

6.  Overview of gene targeting by homologous recombination.

Authors:  Richard Mortensen
Journal:  Curr Protoc Neurosci       Date:  2007-07

7.  Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

Authors:  C A Mullen; M Kilstrup; R M Blaese
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Enhancing the efficiency of introducing precise mutations into the mouse genome by hit and run gene targeting.

Authors:  P Dickinson; W L Kimber; F M Kilanowski; S Webb; B J Stevenson; D J Porteous; J R Dorin
Journal:  Transgenic Res       Date:  2000-02       Impact factor: 2.788

9.  Treatment of colon cancer cells using the cytosine deaminase/5-fluorocytosine suicide system induces apoptosis, modulation of the proteome, and Hsp90beta phosphorylation.

Authors:  Luc Negroni; Michel Samson; Jean-Marie Guigonis; Bernard Rossi; Valérie Pierrefite-Carle; Christian Baudoin
Journal:  Mol Cancer Ther       Date:  2007-10       Impact factor: 6.261

10.  Use of integrase-minus lentiviral vector for transient expression.

Authors:  Touraj Farazmandfar; Hossein Khanahmad Shahreza; Mohammad Reza Haghshenas; Ghasem Janbabai; Hossein Azadeh; Nader Mansour Samaei
Journal:  Cell J       Date:  2012-08-31       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.